All the premium content at PrimeInvestor

Paid subscribers can read timely, actionable recommendations from our experts!
A PrimeInvestor subscription gets you not just invaluable recommendations, rankings, and review tools. It keeps you up-to-date with the latest from the financial marketplace and tells you what you should be doing right now!
Prime Stock update: This automation play may be in takeoff mode
Stocks

Prime Stock update: This automation play may be in takeoff mode 

When a company, especially an MNC, discloses little by way of scheduled earnings calls or business information, save for its AGM, its stock price can also react only to earnings or move on visibility in prospects of the company. We took that risk in one such company which is in the business of automation, in late 2021. 

Premium article available only to subscribers.

Read More »
Prime Stock Recommendation: A consumer stock on a compounding journey
Stocks

Prime Stock Recommendation: A consumer stock on a compounding journey

With consumer companies having pulled through a period of demand slump, the worst appears to be behind. Signs of a recovery in rural demand can help broad-base the overall consumption improvement. This consumer company gets a strong foundation in its household brand names. But it has been evolving from building up its own health and …

Prime Stock Recommendation: A consumer stock on a compounding journey Read More »

Premium article available only to subscribers.

Read More »
Prime stock recommendation - A steady player in the challenging API business
Stocks

Prime Stock recommendation: A steady player in the challenging API business

Pharma companies in the API (Active Pharmaceutical Ingredient) space in India have struggled in the past couple of years, confronted by rising input costs, poor price realization and competition from China even while remaining dependent on China for inputs. All these also impact the even-otherwise modest margins.
Some of these challenges appear to be abating, providing an opportunity to pick select API players in the pharma space.

Premium article available only to subscribers.

Read More »
Login to your account
OR